Prescription Patterns of Cardiovascular Medications in the Adolescent and Adult Population With Fontan Circulation—A Report From the Multicenter Single Ventricle Outcomes Network
10 affiliations
- 1Division of Cardiovascular Medicine, Department of Internal Medicine The Ohio State University Wexner Medical Center Columbus OH USA
- 2Division of Cardiology, Department of Pediatrics Children's Hospital of Philadelphia Philadelphia PA USA
- 3Division of Cardiovascular Medicine, Department of Medicine Hospital of the University of Pennsylvania Philadelphia PA USA
- 4Department of Pediatrics Duke University Medical Center Durham NC USA
- 5Division of Cardiology Phoenix Children's Hospital, University of Arizona Phoenix Phoenix AZ USA
- 6Division of Pediatric Cardiology, Department of Pediatrics University of Utah Salt Lake City UT USA
- 7Division of Cardiology, Department of Pediatrics Texas Children's Hospital, Baylor College of Medicine Houston TX USA
- 8Department of Pediatrics University of Alberta Edmonton Alberta Canada
- 9Adult Congenital Heart Disease Program, Heart Institute, Cincinnati Children's Hospital Medical Center Cincinnati OH USA
- 10Department of Pediatrics University of Cincinnati College of Medicine Cincinnati OH USA
Abstract
Background: There are limited data on prescription patterns in adolescents and adults with Fontan circulation.
Methods: We conducted a retrospective analysis of patients 13 years of age and older enrolled between 2022 and 2024 in the Fontan Outcomes Network (now SV‐ONE [Single Ventricle Outcomes Network]) who had undergone Fontan operation without subsequent Fontan takedown or heart transplantation. Demographics, clinical variables, and medications prescribed were assessed. Logistic regression was used to identify factors associated with prescribed cardiac medications.
Results: There were 639 patients (age range 13–67 years, 55.6% male, 81.1% White race, 46.8% dominant left ventricle) enrolled at 16 centers. The most frequently prescribed medication classes were antiplatelets (75.6%) and renin‐angiotensin system inhibitors (55.9%). Direct oral anticoagulant prescription (15.0%) exceeded that of warfarin (11.6%). SGLT2 (sodium glucose cotransporter 2) inhibitors were prescribed to 6.3% of patients, and angiotensin receptor/neprilysin inhibitors were prescribed to 2.2%. Moderate or severely decreased systolic ventricular function was most strongly associated with prescription of digoxin (odds ratio [OR], 4.2 [95% CI, 2.1–8.3]). Protein losing enteropathy was most strongly associated with prescription of diuretics (OR, 22.9 [95% CI, 8.1–64.9]), mineralocorticoid receptor agonists (OR, 5.3 [95% CI, 2.4–11.8]), and pulmonary vasodilators (OR, 5.2 [95% CI, 2.5–10.8]).
Conclusions: In a multicenter cohort of adolescents and adults with Fontan circulation, medications indicated for biventricular heart failure with reduced ejection fraction are often used despite an absence of supportive evidence in this distinct circulation. Future prospective analysis may provide further insight into shifting prescribing patterns and response to therapy.
Related
- Effectiveness of Discrete Strategies and Implementation Bundles for Improving Clinician Prescription of Clinical Practice Guideline–Recommended Medications for Atherosclerotic Occlusive Disease: A Systematic Review and Meta‐Analysis
- Endovascular therapy in acute anterior circulation large vessel occlusive patients with low NIHSS (ORIENTAL ENDOLOW): protocol of a multicenter randomized clinical trial
- Heart transplant in an adult patient with dysfunctional Fontan circulation at a high-complexity cardiovascular center in Peru: A case report
- Advanced Imaging of the Right Heart and Pulmonary Circulation: The Role of Echocardiography and Cardiovascular Magnetic Resonance
- Psychotropic and cardiovascular medications use among parents of children with special needs
BibTeX
@article{freddo2026prescription,
title = {{Prescription Patterns of Cardiovascular Medications in the Adolescent and Adult Population With Fontan Circulation—A Report From the Multicenter Single Ventricle Outcomes Network}},
author = {Andrew M. Freddo and Humera Ahmed and Jonathan B. Edelson and Sara Partington and Emily Ruckdeschel and Allison L. Tsao and Juan M. Ortega‐Legaspi and Yuli Y. Kim and Adeola O. Awujoola and Deepti P. Bhat and Reid C. Chamberlain and Sharon Chen and Stephen J. Dolgner and Andrew S. Mackie and Alexander R. Opotowsky and Sumeet Vaikunth and the SV‐ONE Investigators},
journal = {Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease},
year = {2026},
month = sep,
doi = {10.1161/jaha.126.049422},
url = {https://doi.org/10.1161/jaha.126.049422},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Prescription Patterns of Cardiovascular Medications in the Adolescent and Adult Population With Fontan Circulation—A Report From the Multicenter Single Ventricle Outcomes Network
AU - Andrew M. Freddo
AU - Humera Ahmed
AU - Jonathan B. Edelson
AU - Sara Partington
AU - Emily Ruckdeschel
AU - Allison L. Tsao
AU - Juan M. Ortega‐Legaspi
AU - Yuli Y. Kim
AU - Adeola O. Awujoola
AU - Deepti P. Bhat
AU - Reid C. Chamberlain
AU - Sharon Chen
AU - Stephen J. Dolgner
AU - Andrew S. Mackie
AU - Alexander R. Opotowsky
AU - Sumeet Vaikunth
AU - the SV‐ONE Investigators
PY - 2026
DA - 2026/09/09
JO - Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
DO - 10.1161/jaha.126.049422
UR - https://doi.org/10.1161/jaha.126.049422
AB - Background: There are limited data on prescription patterns in adolescents and adults with Fontan circulation. Methods: We conducted a retrospective analysis of patients 13 years of age and older enrolled between 2022 and 2024 in the Fontan Outcomes Network (now SV‐ONE [Single Ventricle Outcomes Network]) who had undergone Fontan operation without subsequent Fontan takedown or heart transplantation. Demographics, clinical variables, and medications prescribed were assessed. Logistic regression was used to identify factors associated with prescribed cardiac medications. Results: There were 639 patients (age range 13–67 years, 55.6% male, 81.1% White race, 46.8% dominant left ventricle) enrolled at 16 centers. The most frequently prescribed medication classes were antiplatelets (75.6%) and renin‐angiotensin system inhibitors (55.9%). Direct oral anticoagulant prescription (15.0%) exceeded that of warfarin (11.6%). SGLT2 (sodium glucose cotransporter 2) inhibitors were prescribed to 6.3% of patients, and angiotensin receptor/neprilysin inhibitors were prescribed to 2.2%. Moderate or severely decreased systolic ventricular function was most strongly associated with prescription of digoxin (odds ratio [OR], 4.2 [95% CI, 2.1–8.3]). Protein losing enteropathy was most strongly associated with prescription of diuretics (OR, 22.9 [95% CI, 8.1–64.9]), mineralocorticoid receptor agonists (OR, 5.3 [95% CI, 2.4–11.8]), and pulmonary vasodilators (OR, 5.2 [95% CI, 2.5–10.8]). Conclusions: In a multicenter cohort of adolescents and adults with Fontan circulation, medications indicated for biventricular heart failure with reduced ejection fraction are often used despite an absence of supportive evidence in this distinct circulation. Future prospective analysis may provide further insight into shifting prescribing patterns and response to therapy.
SN - 2047-9980
ER -